精神分裂症中AKT同种型表达的神经元改变
本研究显示精神分裂症患者神经元中AKT1-3的mRNA表达升高,与既往死后研究中总AKT蛋白表达不变或降低的报道相反,提示转录与蛋白水平可能解耦联。观察到性别特异性的AKT活性差异,且PDPK1、多种蛋白磷酸酶及FOXO1表达上调,这些改变大多独立于抗精神病药物使用。
要点
- 精神分裂症患者神经元中AKT1-3的mRNA表达升高,与总AKT蛋白表达不变或降低的既往报道相反。
- 观察到性别特异性的AKT活性差异,提示男性和女性患者中AKT作用不同。
- PDPK1、多种蛋白磷酸酶及FOXO1表达上调,改变大多独立于抗精神病药物使用。
核心结论
- 精神分裂症患者神经元中AKT1-3的mRNA表达升高,与既往报道的总AKT蛋白表达不变或降低相反,提示转录与蛋白水平可能解耦联。
- 这些改变可能代表对经典胰岛素信号通路原发缺陷的代偿反应。
- 研究强调需要详细理解这些信号通路以开发有效的治疗策略。
研究设计与样本
- 本研究为死后脑组织研究,检测精神分裂症受试者神经元中AKT1-3的mRNA表达、AKT活性及相关信号分子表达。
主要发现
- 精神分裂症受试者神经元中AKT1-3的mRNA表达升高,而既往死后研究报告总AKT蛋白表达不变或降低。
- 观察到性别特异性的AKT活性差异,提示AKT在男性和女性精神分裂症患者中作用不同。
- PDPK1及多种调节AKT的蛋白磷酸酶表达上调。
- 转录因子FOXO1表达增强,提示可能存在与胰岛素信号失调相关的代偿机制。
- 上述发现大多独立于抗精神病药物使用,提示精神分裂症存在固有改变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia is characterized by substantial alterations in brain function, and previous studies suggest insulin signaling pathways, particularly involving AKT, are implicated in the pathophysiology of the disorder. This study demonstrates elevated mRNA expression of AKT1-3 in neurons from schizophrenia subjects, contrary to unchanged or diminished total AKT protein expression reported in previous postmortem studies, suggesting a potential decoupling of transcript and protein levels. Sex-specific differential AKT activity was observed, indicating divergent roles in males and females with schizophrenia. Alongside AKT, upregulation of PDPK1, a critical component of the insulin signaling pathway, and several protein phosphatases known to regulate AKT were detected. Moreover, enhanced expression of the transcription factor FOXO1, a regulator of glucose metabolism, hints at possible compensatory mechanisms related to insulin signaling dysregulation. Findings were largely independent of antipsychotic medication use, suggesting inherent alterations in schizophrenia. These results highlight the significance of AKT and related signaling pathways in schizophrenia, proposing that these changes might represent a compensatory response to a primary defect of canonical insulin signaling pathways. This research underscores the need for a detailed understanding of these signaling pathways for the development of effective therapeutic strategies.
引用
- Devine EA, Imami AS, Eby H, et al. Neuronal alterations in AKT isotype expression in schizophrenia. Mol Psychiatry. 2024. PMID: 39424930. doi:10.1038/s41380-024-02770-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。